Cotadutide acetate

Cotadutide acetate is a synthetic peptide compound that functions as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors. Structurally engineered to mimic endogenous peptide hormones, it exhibits unique pharmacodynamic properties that have garnered significant interest within metabolic research and peptide pharmacology. Its dual receptor activity enables the modulation of multiple metabolic pathways, making it an invaluable tool for investigating complex endocrine signaling, energy homeostasis, and peptide-receptor interactions. As a research-use-only reagent, cotadutide acetate offers a reliable means to interrogate the molecular mechanisms underlying metabolic regulation and peptide-based signaling cascades.

Metabolic pathway elucidation: Researchers employ cotadutide acetate to dissect the integrated signaling networks of GLP-1 and glucagon receptors in metabolic tissues. By activating both receptor subtypes, the peptide facilitates the study of crosstalk between insulinotropic and glucagonotropic pathways, enabling detailed analyses of glucose homeostasis, hepatic glucose output, and lipid metabolism. This dual agonist model supports investigations into the physiological roles of incretin and glucagon systems in energy balance and metabolic adaptation.

Peptide receptor pharmacology: The compound serves as a robust tool for characterizing receptor binding affinities, downstream signaling events, and functional selectivity in cellular and tissue-based assays. Its well-defined structure and dual activity profile allow for precise evaluation of receptor activation, desensitization, and cross-regulation, providing valuable insights into the pharmacological modulation of peptide hormone receptors. Such studies are critical for advancing the understanding of receptor dynamics and ligand specificity within the GPCR superfamily.

Peptide synthesis and analog development: Cotadutide acetate is often utilized as a reference standard or template in the synthesis of novel peptide analogs targeting metabolic receptors. Its sequence and dual-agonist properties inform structure-activity relationship (SAR) studies aimed at optimizing peptide stability, bioactivity, and selectivity. By serving as a benchmark compound, it supports the rational design and screening of next-generation peptide therapeutics and research probes.

Cell signaling research: In vitro and ex vivo models benefit from the application of this dual agonist to probe intracellular signaling cascades downstream of GLP-1 and glucagon receptor activation. Researchers leverage its activity to map second messenger systems, such as cAMP production and PKA pathway engagement, as well as to investigate the interplay between metabolic signaling and cellular energy sensors. These studies enhance the mechanistic understanding of peptide-driven cellular responses in metabolic tissues.

Assay development and validation: The reliable pharmacological profile of cotadutide acetate makes it an ideal positive control or reference ligand in a variety of bioanalytical and receptor-based assays. Its use in assay calibration, validation, and performance benchmarking ensures reproducibility and accuracy in high-throughput screening, ligand binding studies, and functional assays targeting GLP-1 and glucagon receptor pathways. This application is essential for laboratories seeking to establish robust and sensitive assay platforms for peptide-receptor research.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats